MPAL.L is trading at £3.40, down 6%, as investors react to a £5 million equity raise priced at a discount to the prior close.

  • The proceeds are intended to fund strategic acquisitions, including Solid State Technologies and the expansion of the company's care-home and pharmacy platforms.
  • While the move supports a long-term growth narrative, the immediate share price pressure reflects market skepticism and concerns regarding share dilution.